Evaluation of serum HER2 extracellular domain in early breast cancer patients: correlation with clinicopathological parameters and survival

Autor: C. Basurto, Vienna Ludovini, Lorenza Pistola, Stefania Gori, Antonio Rulli, E. Pacifico, M. Colozza, Francesca Romana Tofanetti, L. Crinò, Irene Floriani, Eliana Rulli, Angelo Sidoni

Publikováno v: Annals of Oncology. 19:883-890

Background We explored the correlation between serum human epidermal growth factor receptor-2 (HER2) extracellular domain (ECD) and tissue HER2 status, their relationship with clinicopathological parameters and their impact on disease-free survival (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab7cc82461433a7dd3a7127408f125e5
https://doi.org/10.1093/annonc/mdm585

Phase II study of weekly paclitaxel and trastuzumab in anthracycline- and taxane-pretreated patients with HER2-overexpressing metastatic breast cancer

Autor: Angelo Sidoni, M. Colozza, C. Basurto, Roberta Cherubini, Maurizio Tonato, V. De Angelis, Anna Maria Mosconi, Enrico Franceschi, Antonio Rulli, Stefania Gori, C. Bisacci, L. Crinò

Publikováno v: British Journal of Cancer

Synergism between anti-HER2 monoclonal antibody (trastuzumab) and paclitaxel has been shown in vitro and in vivo. In previous experiences, weekly administration of trastuzumab and paclitaxel has shown significant activity in metastatic breast cancer.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc7862bd332a7a3e1153b7e4276fd508
http://europepmc.org/articles/PMC2395328

Survival, quality of life and breast cancer

Autor: S. De Placido, M. Maltoni, Paola Mosconi, M. De Laurentiis, M. Colozza

Publikováno v: Scopus-Elsevier

In recent years, evaluating quality of life (QoL) has become increasingly important as an additional measured outcome in cancer clinical trials, in particular in the field of breast cancer. This paper, after a general introduction to the present deba

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3dae0d2126a0b33c1488c679246aa53
https://doi.org/10.1093/annonc/12.suppl_3.s15

Induction Chemotherapy with Cisplatin, Doxorubicin, and Cyclophosphamide (CAP) in a Combined Modality Approach for Locally Advanced and Inflammatory Breast Cancer

Autor: M. Colozza, U. Mercati, Anna Maria Mosconi, P. Anastasi, M. Giansanti, Paolo Latini, V. De Angelis, Cynthia Aristei, Maurizio Tonato, Stefania Gori

Publikováno v: American Journal of Clinical Oncology. 19:10-17

Thirty-one patients with locally advanced and inflammatory breast carcinoma (stage IIIA and IIIB) were treated with a combined modality approach between 1985 and 1989. All patients received as induction chemotherapy a combination of cisplatin, doxoru

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4c8ad8323c4c265998cc818e947cf93
https://doi.org/10.1097/00000421-199602000-00003

Treatment

Autor: C. S. Goodwin, B. Worsley, E. Pillai, V. Willems, H. D. Janisch, H. Langmaack, P. Sanchez, M. Alcalde, A. Lancho, P. Carpintero, R. Garcia, J. M. Pajares, P. Ya. Grigoriev, V. A. Isakov, E. P. Iakovenko, A. V. Iakovenko, K. Vogt, H. Hahn, I. H. Rehmann, M. Hedding-Eckerich, J. Blessing, G. M. Sobala, D. A. F. Lynch, B. Gallacher, M. F. Dixon, A. T. R. Axon, E. Bayerdörffer, G. Mannes, A. Sommer, W. Höchter, J. Weingart, R. Hatz, S. Miehlke, N. Lehn, G. Ruckdeschel, P. Dirschedl, M. Stolte, R. J. Adamek, M. Wegener, S. Birkholz, W. Opferkuch, G. H. Rühl, B. Wedmann, J. Labenz, E. Gyenes, G. H. R’hl, G. Börsch, R. Maieron, C. Rizzi, L. Zoratti, S. Andreoli, G. L. Da Broi, C. A. Beltrami, Zhuya Chengyl, Mou Yangiong, Hua Jiesong, Zhang Zhenhua, L. Bierti, E. G. Bolis, R. Di Battista, R. de Franchis, D. J. McAvinchey, M. Laurence, J. O’Riordan, M. Fantazi, M. Khawaja, E Bologna, M. Stroppiana, S. Peyre, R. Pulitano’, C. Sategna-Guidetti, E. Martin, T. Alarcön, J. C. Sanz, M. I. Jimonez, M. López-Brea, A. Burette, Y. Glupczynski, C. Deprez, F. Di Mario, M. Ferrana, G. Battaglia, P. Dotto, F. Vianello, G. A. Grasso, R. Fiocca, L. Villiani, O. Luinetti, A. Gianatti, R. Boldorini, M. Lazzaroni, G. Bianchi Porro, E. Trespi, M. Perego, C. Alvisi, B. Cesana, E. Solcia, R. P. H. Logan, R. R. Greaves, P. A. Gummett, M. M. Walker, Q. N. Karim, A. E. Duggan, J. H. Baron, J. J. Misiewicz, J. Lohmarm, L. H. H. Porst, J. Schönlebe, H. Riedel, F. Catalano, G. Rizzo, M. T. Ayoubi Khajekini, G. Branciforte, G. Inserra, A. Liberti, R. Suriani, C. Pallante, M. Ravizza, D. Mazzucco, D. Galliano, M. Malandrino, R. Oneglio, M. Colozza, E. Gaia, F. Sallio, D. Colozza, C. Grandis, G. B. Forte, M. E. Bottiglieri, R. Durasco, E. Grimaldi, P. Rocco, H. X. Xia, M. A. Daw, S. Sant, S. Beattie, C. T. Keane, C. A. O’Morain, H. Larsson, M. L. Berglund, P. Tessaro, R. Schiavon, M. G. Contini, T. Ton, L. Norberto, M. Cassaro, M. Rugge, M. Guido, R. Baffa, S. Gloriosa, F. Turatello, R. Naccarato, R. Collins, C. O’Moram, T. P. Kemmer, J. E. Dominguez-Munoz, H. Klingel, P. Malfertheiner, C. J. McCarthy, M. McDermott, D. Hourihane, C. O’Morain, M. T. Droy-Lefiax, B. Forestier, D. Guillomain, O. Plique, D. Brugmann, F. Mégraud, H. Lamouliatte, P. H. Bernard, R. Cayla, M. Mégraud, A. de Mascarel, A. Quintonl, A. McLaren, S. R. McDowell, A. A. McColm, C. O’Malley, J. Bagshaw, F. Bouffant, P. Marelli, L. Cellini, M. Campa, B. Dainelli, G. Soldani, M. del Tacca, G. Ferrini, G. Larcinese, N. Semperlotti, Gy. Molnar, A. Fzentmihalyi, A. Takats, G. Gero, J. Penyige, Gy. Mark, J. Martínez-Gómez, D. García-Novo, D. Acuña-Quinõs, M. Gimeno, S. Vigneri, R. Termini, A. Scialabba, G. Pisciotta, R. Gusmaroli, F. Milesi, P. Mule, M. Menegatti, C. Reale, J. Holten, D. Vaira

Publikováno v: Irish Journal of Medical Science. 161:88-100

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c424d75d8ced123470d6b4147ec2cf76
https://doi.org/10.1007/bf02942895